PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Arrhythmia 29,330 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Dehydration 21,928 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Diarrhea 51,986 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Major Depressive Disorder 12,517 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Epilepsy 71,172 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Dyslipidemia 15,225 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51